Objectives: The overall aim of our research project is to develop a Next Generation Sequencing
strategy to identify metabolic disorders in 104 patients with a presumptive diagnosis of
primary progressive MS.We would like to thank to MERCK, SA and NORTE2020 (NORTE-01-0246-FEDER-000014) for funding
this Project.N/
